Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Property:RefTags

From GxPlex

Jump to: navigation, search

Text

Raw TAG-ID list for this reference (used for glossary queries).

previous 202050100250500next 20
Showing 20 pages using this property.
U
USA 21 CFR Part 312 09-Apr-2025 § 312.50 +
TAG-00245-Spo-ten ++ TAG-00017-Spo-die ++ TAG-00137-Mon-che ++ TAG-00018-Inv-die ++ TAG-00320-Foo-eri  +
USA 21 CFR Part 812 09-Apr-2025 § 812.45 +
TAG-00245-Spo-ten ++ TAG-00017-Spo-die ++ TAG-00034-Inv-Bro ++ TAG-00155-Med-Med ++ TAG-00203-Cli-lin  +
USA 21 CFR Part 812 09-Apr-2025 § 812.43 +
TAG-00245-Spo-ten ++ TAG-00018-Inv-die ++ TAG-00137-Mon-che ++ TAG-00060-Del-ben ++ TAG-00155-Med-Med  +
USA 21 CFR Part 312 09-Apr-2025 § 312.53 +
TAG-00245-Spo-ten ++ TAG-00018-Inv-die ++ TAG-00137-Mon-che ++ TAG-00060-Del-ben ++ TAG-00320-Foo-eri  +
D
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b Absatz 6-002 +
TAG-00245-Spo-ten ++ TAG-00063-Dat-per ++ TAG-00029-Inf-rte ++ TAG-00028-Leg-ich ++ TAG-00017-Spo-die  +
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b-002 +
TAG-00245-Spo-ten ++ TAG-00063-Dat-per ++ TAG-00029-Inf-rte ++ TAG-00028-Leg-ich ++ TAG-00025-Sub-mer  +
E
EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter III 2. ; 7. +
TAG-00245-Spo-ten ++ TAG-00111-Agr-chr ++ TAG-00046-Ser-sSc ++ TAG-00203-Cli-lin ++ TAG-00201-Cli-eSt  +
EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 2 +
TAG-00245-Spo-ten ++ TAG-00111-Agr-chr ++ TAG-00046-Ser-sSc ++ TAG-00043-Goo-tek  +
I
ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 9 +
TAG-00245-Spo-ten ++ TAG-00148-Con-rsc ++ TAG-00137-Mon-che ++ TAG-00201-Cli-eSt ++ TAG-00111-Agr-chr  +
ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 9.2.5 +
TAG-00245-Spo-ten ++ TAG-00329-Saf-lne ++ TAG-00258-Ser-nfü ++ TAG-00213-Ser-wie ++ TAG-00201-Cli-eSt  +
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.4 - immediate hazard +
TAG-00246-Inv-hte ++ TAG-00017-Spo-die ++ TAG-00069-Imm-rhe ++ TAG-00041-Ame-run ++ TAG-00329-Saf-lne  +
D
DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 62-001 +
TAG-00246-Inv-hte ++ TAG-00019-Pri-Prü ++ TAG-00201-Cli-eSt ++ TAG-00231-Per-ung ++ TAG-00134-Eth-kom ++ TAG-00343-Doc-ten  +
DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 62-002 +
TAG-00246-Inv-hte ++ TAG-00019-Pri-Prü ++ TAG-00201-Cli-eSt ++ TAG-00231-Per-ung ++ TAG-00134-Eth-kom ++ TAG-00343-Doc-ten  +
DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 62-003 +
TAG-00246-Inv-hte ++ TAG-00019-Pri-Prü ++ TAG-00201-Cli-eSt ++ TAG-00231-Per-ung ++ TAG-00134-Eth-kom ++ TAG-00343-Doc-ten  +
U
USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 1.3 +
TAG-00246-Inv-hte ++ TAG-00019-Pri-Prü ++ TAG-00045-Adv-hte ++ TAG-00259-AEs-ten ++ TAG-00066-Cau-enh  +
I
ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.1 +
TAG-00246-Inv-hte ++ TAG-00019-Pri-Prü ++ TAG-00329-Saf-lne ++ TAG-00129-Dat-ali ++ TAG-00201-Cli-eSt  +
U
USA 21 CFR Part 312 09-Apr-2025 § 312.53 (c) (vi) +
TAG-00246-Inv-hte ++ TAG-00033-Pro-oto ++ TAG-00011-Inv-tud ++ TAG-00041-Ame-run ++ TAG-00320-Foo-eri ++ TAG-00328-Com-egu  +
USA 21 CFR Part 312 09-Apr-2025 § 312.53 (c) (vi) - (vii) +
TAG-00246-Inv-hte ++ TAG-00033-Pro-oto ++ TAG-00011-Inv-tud ++ TAG-00041-Ame-run ++ TAG-00320-Foo-eri ++ TAG-00328-Com-egu  +
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.6 +
TAG-00246-Inv-hte ++ TAG-00034-Inv-Bro ++ TAG-00011-Inv-tud ++ TAG-00329-Saf-lne  +
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 3.2 - Consultation +
TAG-00246-Inv-hte ++ TAG-00134-Eth-kom ++ TAG-00033-Pro-oto ++ TAG-00029-Inf-rte  +
Retrieved from "https://gxplex.org/index.php?title=Property:RefTags&oldid=20452"